| Ytd | -31.91% | |
| 1y | -43.12% |
| Open | 36.23 | Prev Close | 36.26 | Low | 36.26 | High | 37.36 | Mkt Cap | 3.16B |
| Vol | 435.91K | Avg Vol | 320.69K | EPS | 3.97 | P/E | 9.20 | Forward P/E | 40.08 |
| Beta | 0.20 | Short Ratio | 3.13 | Inst. Own | 38.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 06-11 | Earning | 05-08 | 50-d Avg | 46.97 | 200-d Avg | 48.84 | 1yr Est | 50.34 |
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQÂ) for the Treatment of Adults and Ado
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP)